Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.6.0.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 3,721,765 $ 5,486,526
Short-term investments, restricted 0 294,802
Accounts receivable, net 8,630,418 5,286,863
Unbilled revenue 2,269,645 1,072,391
Inventory, net 4,774,264 5,683,043
Due from related party 260,988 1,177,261
Deferred financing costs 0 48,989
Prepaid and other current assets 401,876 353,105
Total current assets 20,058,956 19,402,980
Property, plant and equipment, net 517,143 543,754
Intangible assets, net 1,065,967 1,044,611
Goodwill 40,870 40,870
Other assets 2,058,425 58,425
TOTAL ASSETS 23,741,361 21,090,640
Current liabilities:    
Accounts payable 3,367,481 3,311,809
Accrued expenses 1,378,258 1,066,860
Deferred revenue 876,765 996,941
Total current liabilities 5,622,504 5,375,610
Long-term liabilities:    
Deferred revenue, net of current portion 459,275 273,162
Convertible Debentures, Related Parties, Noncurrent 3,148,509 3,000,000
Total liabilities 9,230,288 8,648,772
Commitments and contingencies (Note 8)
Tecogen Inc. shareholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized; 19,981,912 and 18,478,990 issued and outstanding at December 31, 2016 and 2015, respectively 19,982 18,479
Additional paid-in capital 37,334,773 34,501,640
Accumulated deficit (22,843,682) (21,682,437)
Total Tecogen Inc. stockholders’ equity 14,511,073 12,837,682
Noncontrolling interest 0 (395,814)
Total stockholders’ equity 14,511,073 12,441,868
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 23,741,361 $ 21,090,640